Clinical trial
Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in…
NCT00242528 · Novartis, Industry · Withdrawn
Key facts
| NCT number | NCT00242528 |
|---|---|
| Title | Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. |
| Official title | Open-label Study, to Evaluate the Safety and Tolerability of Zoledronic Acid in Patients With Bone Lesions Secondary to Multiple Myeloma. |
| Lead sponsor | Novartis, Industry |
| Status | Withdrawn |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Multiple Myeloma |
| Intervention type | Drug |
| Interventions | Zoledronic acid |
| Enrollment | 0 |
| Start date | Apr 1, 2004 |
| First posted | Oct 20, 2005 |
| Last update posted | Apr 14, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: